23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
March of Dimes Updates: Integrating genetics into your practice
November 1st 2003Ob/gyns are having to devote significantly more time to medical genetics because of the field's increasing impact on clinical practice. The March of Dimes's new online genetics resource and continuing education program can help you respond to patients'needs with the most up-to-date, customized, and practical information
Read More
Offering high-quality ob/gyn care for lesbian patients
September 1st 2003Most lesbian patients hesitate to reveal their sexual orientation, even though you need that information to deliver targeted health care. Creating a nonjudgmental office environment can encourage trust and disclosure, helping you to better address their unique health needs.
Read More
How do you code for well-woman exams?
April 1st 2002Coding and reimbursement for Medicare well-woman screening exams is one of the biggest challenges in ob/gyn coding. You must know whether a patient meets Medicare's criteria for "high risk" or "low risk." This risk factor determines the frequency with which Medicare pays for well-woman care.
Read More
Cover Story/CME: Evaluation and treatment of unwanted hair growth
February 1st 2002Whether the etiology is androgen excess or something more benign, excess hair growth negatively impacts quality of life for millions of women. A thorough evaluation is required to uncover underlying causes and provide appropriate treatment.
Read More
BRCA1 and BRCA2: Genetic testing and intervention strategies
July 1st 2001Who should undergo genetic testing? Before ordering it, three conditions should be met: There should be a greater than 10% likelihood of a positive test; the ordering physician should be able to interpret the result; and the information should be used to make management decisions.
Read More
CME: Offering mifepristone as an abortion option
February 1st 2001While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Read More